Cargando…
6-Thioguanosine Monophosphate Prodrugs Display Enhanced Performance against Thiopurine-Resistant Leukemia and Breast Cancer Cells
[Image: see text] Thiopurines are in widespread clinical use for the treatment of immunological disorders and certain cancers. However, treatment failure due to resistance or adverse drug reactions are common, asking for new therapeutic strategies. We investigated the potential of 6-thioguanosine mo...
Autores principales: | Moreno, Sarah, Fickl, Magdalena, Bauer, Ingo, Brunner, Melanie, Rázková, Anna, Rieder, Dietmar, Delazer, Isabel, Micura, Ronald, Lusser, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706553/ https://www.ncbi.nlm.nih.gov/pubmed/36374020 http://dx.doi.org/10.1021/acs.jmedchem.2c01010 |
Ejemplares similares
-
Synthesis of 4-thiouridines with prodrug functionalization for RNA metabolic labeling
por: Moreno, Sarah, et al.
Publicado: (2022) -
Thioguanosine Conversion Enables mRNA‐Lifetime Evaluation by RNA Sequencing Using Double Metabolic Labeling (TUC‐seq DUAL)
por: Gasser, Catherina, et al.
Publicado: (2020) -
Converging Fate of the Oxidation and Reduction of 8-Thioguanosine
por: Taras-Goslinska, Katarzyna, et al.
Publicado: (2019) -
Thermodynamic and structural contributions of the 6-thioguanosine residue to helical properties of RNA
por: Gładysz, Michał, et al.
Publicado: (2019) -
Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain
por: Amort, Thomas, et al.
Publicado: (2017)